Orphazyme A/S (ORPHA.CO)
- Previous Close
1,100.00 - Open
975.10 - Bid --
- Ask --
- Day's Range
975.10 - 1,099.00 - 52 Week Range
407.00 - 5,370.00 - Volume
30 - Avg. Volume
87 - Market Cap (intraday)
38.49M - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
-- - EPS (TTM)
-17,050.00 - Earnings Date May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
www.orphazyme.comRecent News: ORPHA.CO
Performance Overview: ORPHA.CO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ORPHA.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ORPHA.CO
Valuation Measures
Market Cap
38.84M
Enterprise Value
-10.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.07
Price/Book (mrq)
0.50
Enterprise Value/Revenue
-0.30
Enterprise Value/EBITDA
0.02
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-21.15%
Return on Equity (ttm)
-94.35%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-26.05M
Diluted EPS (ttm)
-17,050.00
Balance Sheet and Cash Flow
Total Cash (mrq)
18.21M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.8M
Company Insights: ORPHA.CO
ORPHA.CO does not have Company Insights